allergic to glp 1 Rare cutaneous adverse reactions associated with GLP-1 agonists: a review of the published literature | Archives of Dermatological Research Delayed type hypersensitivity injection site

Denials for diabetes indications are usually fixable with better documentation, while denials for weight management often require an appeal or a plan exception request

[DOI] [PMC free article] [PubMed] [Google Scholar] 43.Dixit AA, et al

Review Article OPEN ACCESS Lun-Gen Lu * Author information Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently a pressing public health issue associated with adverse outcomes such as cirrhosis, malignancy, transplantation, and mortality

However, some foods should be reduced or avoided altogether if possible

The National Institute for Health and Care Excellence (NICE) provides guidance on the use of GLP-1 receptor agonists in guideline NG28, recommending them for type 2 diabetes in specific contexts, such as when other therapies have proven inadequate, particularly in people with higher BMI or cardiovascular risk factors

Its the active ingredient in Zepbound (weight loss) and Mounjaro (Type 2 diabetes)